Clinical Trial Update: ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System [NA]

View source ↗

Summary

The document reports the completion of Abbott's ESPRIT I clinical evaluation of the ESPRIT bioresorbable vascular scaffold system and the posting of results in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Intermittent Claudication
• Peripheral Artery Disease

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atherosclerosis, Peripheral Vascular Disease | NA | Status: COMPLETED | Results posted: 2019-02-04